SCHEMBL20914035

SCHEMBL20914035

COc1cc(Cl)cc2oc(-c3c(C)[nH]c4c(-c5ccccc5)c(C#N)nn4c3=O)nc12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAT2A P31153 2/20 0.34
▸ HPGD P15428 8/20 0.33
▸ HSD17B10 Q99714 8/20 0.33
▸ HTT P42858 6/20 0.33
▸ ALDH1A1 P00352 6/20 0.33
▸ KDM4E B2RXH2 6/20 0.33
▸ LMNA P02545 5/20 0.33
▸ NPSR1 Q6W5P4 2/20 0.33
▸ TSHR P16473 2/20 0.33
▸ NOD2 Q9HC29 1/20 0.33
▸ MAPT P10636 6/20 0.33
▸ MEN1 O00255 6/20 0.32
▸ KMT2A Q03164 6/20 0.32
▸ APAF1 O14727 1/20 0.32
▸ GAA P10253 2/20 0.32
▸ DCTPP1 Q9H773 2/20 0.31
▸ PKM P14618 2/20 0.31
▸ CYP1A2 P05177 1/20 0.31
▸ CYP2C9 P11712 1/20 0.31
▸ TP53 P04637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20914059 0.91 MAT2A (0.33) MAT2AHPGDHSD17B10HTTALDH1A1
SCHEMBL20914077 0.89 TNKS (0.37) MAT2AHPGDHSD17B10HTTALDH1A1
SCHEMBL20913910 0.89 HPGD (0.33) MAT2AHPGDHSD17B10HTTALDH1A1
SCHEMBL20914019 0.89 PLAT (0.32) MAT2AHPGDHSD17B10HTTALDH1A1
SCHEMBL20836952 0.88 MAT2A (0.33) MAT2AHPGDHSD17B10HTTALDH1A1
SCHEMBL20914141 0.86 HSD17B10 (0.32) MAT2AHPGDHSD17B10HTTALDH1A1
SCHEMBL20914066 0.85 ARF6 (0.39) ALDH1A1KDM4ENPSR1TSHRMAPT
SCHEMBL20914018 0.85 MAT2A (0.34) MAT2AHSD17B10HTTALDH1A1KDM4E
SCHEMBL20914108 0.85 MAT2A (0.34) MAT2AHPGDHSD17B10HTTALDH1A1
SCHEMBL20837047 0.85 MAT2A (0.33) MAT2AHPGDHTTNPSR1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10738056-B2 Pyrazolopyrimidinone compounds and uses thereof ADURO BIOTECH INC. (US) 2020-08-11 — — US disclosed
US-20190119285-A1 PYRAZOLOPYRIMIDINONE COMPOUNDS AND USES THEREOF CHINOOK THERAPEUTICS, INC. 2019-04-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10738056-B2 Pyrazolopyrimidinone compounds and uses thereof NLRP3, NLRP1, P2RX7 MAT2A 1893/4885HPGD 280/4885HSD17B10 3047/4885
US-20190119285-A1 PYRAZOLOPYRIMIDINONE COMPOUNDS AND USES THEREOF NLRP3, NLRP1, P2RX7 MAT2A 1893/4885HPGD 280/4885HSD17B10 3047/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback